| Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators. | |
| | |
MedLine Citation:
|
PMID: 23361837 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE Patients with bipolar disorder have high levels of cardiovascular disease risk factors. The presence of metabolic syndrome significantly influences future cardiovascular disease morbidity and mortality. The authors sought to clarify the prevalence and moderators of metabolic syndrome in bipolar patients, accounting for subgroup differences. METHOD The authors searched MEDLINE, PsycINFO, EMBASE, and CINAHL through April 2012 for research reporting metabolic syndrome prevalence rates in bipolar patients. Medical subject headings "metabolic syndrome" and "bipolar" were used in the title, abstract, or index term fields. Manual searches were conducted using the reference lists from identified articles. RESULTS The search yielded 81 articles in 37 publications (N=6,983). The overall metabolic syndrome rate was 37.3% (95% confidence interval [CI]=36.1-39.0) using any standardized metabolic syndrome criteria. Compared with general population groups, bipolar patients had higher metabolic syndrome rates (odds ratio=1.98; 95% CI=1.74-2.25). In bipolar patients, older age had a modest effect on the metabolic syndrome rate. The strongest moderator was the region in which the study took place, with the highest rates observed in New Zealand and Australia (64.2% [95% CI=38.3-83.9]) and North America (49.3% [95% CI=29.7-69.3]). Metabolic syndrome was significantly more prevalent in patients currently treated with antipsychotics (45.3% [95% CI=39.6-50.9] than in patients who were antipsychotic free (32.4% [95% CI=27.5-37.4]; odds ratio=1.72 [95% CI=1.24-2.38]). CONCLUSIONS These findings strongly support the claim that patients with bipolar disorder are at high risk for metabolic syndrome and related cardiovascular morbidity and mortality and require regular monitoring and adequate preventive efforts and treatment for cardio-metabolic risk factors. These findings further suggest that the risk of metabolic syndrome is greater in bipolar patients taking prescribed antipsychotic medication. |
| | |
Authors:
|
Davy Vancampfort; Kristof Vansteelandt; Christoph U Correll; Alex J Mitchell; Amber De Herdt; Pascal Sienaert; Michel Probst; Marc De Hert |
Related Documents
:
|
12760437 - Left-sided facial nevus with contralateral leptomeningeal angiomatosis in a child with ... 2282617 - Psychopathology in sturge-weber syndrome. 4011357 - Facial port-wine stains and sturge-weber syndrome. 15575847 - Phakomatosis pigmentovascularis type iib associated with sturge-weber syndrome. 18435847 - The greig cephalopolysyndactyly syndrome. 23604607 - Fryns syndrome: a lethal birth defect with variable phenotypic expressions in siblings. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-30 |
Journal Detail:
|
Title: The American journal of psychiatry Volume: - ISSN: 1535-7228 ISO Abbreviation: Am J Psychiatry Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370512 Medline TA: Am J Psychiatry Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study.
Next Document: Does an Upper Respiratory Tract Infection During Pregnancy Affect Perinatal Outcomes? A Literature R...